Curbstone Financial Management Corp Buys 11,616 Shares of CVS Health Corp (NYSE:CVS)

Share on StockTwits

Curbstone Financial Management Corp raised its stake in CVS Health Corp (NYSE:CVS) by 46.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,456 shares of the pharmacy operator’s stock after acquiring an additional 11,616 shares during the period. Curbstone Financial Management Corp’s holdings in CVS Health were worth $1,986,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Brookmont Capital Management grew its position in CVS Health by 3.0% during the 4th quarter. Brookmont Capital Management now owns 5,184 shares of the pharmacy operator’s stock worth $340,000 after acquiring an additional 152 shares during the last quarter. First City Capital Management Inc. grew its position in CVS Health by 0.9% during the 4th quarter. First City Capital Management Inc. now owns 21,433 shares of the pharmacy operator’s stock worth $1,404,000 after acquiring an additional 181 shares during the last quarter. Capital Investment Advisory Services LLC grew its position in CVS Health by 3.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock worth $277,000 after acquiring an additional 189 shares during the last quarter. Virginia National Bank grew its position in shares of CVS Health by 4.9% in the 1st quarter. Virginia National Bank now owns 4,100 shares of the pharmacy operator’s stock valued at $221,000 after buying an additional 190 shares during the last quarter. Finally, Burke & Herbert Bank & Trust Co. grew its position in shares of CVS Health by 2.8% in the 1st quarter. Burke & Herbert Bank & Trust Co. now owns 7,466 shares of the pharmacy operator’s stock valued at $402,000 after buying an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 77.18% of the company’s stock.

Shares of CVS Health stock opened at $58.84 on Friday. The company has a market cap of $77.83 billion, a PE ratio of 8.11, a price-to-earnings-growth ratio of 1.31 and a beta of 0.90. CVS Health Corp has a 52 week low of $51.72 and a 52 week high of $82.15. The business has a 50 day moving average price of $56.32 and a 200-day moving average price of $56.32. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, topping the consensus estimate of $1.70 by $0.19. The firm had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The company’s quarterly revenue was up 35.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.69 earnings per share. As a group, research analysts anticipate that CVS Health Corp will post 6.96 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.40%. The ex-dividend date of this dividend was Wednesday, July 24th. CVS Health’s payout ratio is 28.25%.

CVS has been the topic of a number of analyst reports. UBS Group reduced their price target on CVS Health from $74.00 to $67.00 and set a “sell” rating on the stock in a research report on Thursday, May 2nd. Raymond James reduced their price target on CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research report on Thursday, April 18th. Standpoint Research upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. BMO Capital Markets set a $63.00 price target on CVS Health and gave the company a “hold” rating in a research report on Friday, May 3rd. Finally, Citigroup upped their price target on CVS Health from $68.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $75.14.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Article: Debt-To-Equity Ratio

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.